Ulka Vaishampayan, MD, presented “Recent Clinical Radionuclide Therapy Advances in mCRPC” for the Grand Rounds in Urology audience in February, 2020.
How to cite: Vaishampayan, Ulka. “Recent Clinical Radionuclide Therapy Advances in mCRPC” February, 2020. Accessed Jan 2021. https://grandroundsinurology.com/recent-clinical-radionuclide-therapy-advances-in-mcrpc/
Recent Clinical Radionuclide Therapy Advances in mCRPC – Summary:
Ulka Vaishampayan, MD, Professor of Oncology at Wayne State University and Chief of Solid Tumor Oncology at the Karmanos Cancer Center, discusses the phase 3 randomized controlled trial of 177-Lutetium-PSMA radionuclide therapy. In this brief summary, Dr. Vaishampayan discusses the mechanism of action of this novel therapy, how to identify patients utilizing a PSMA-based PET scan, and the inclusion/exclusion criteria from the phase 3 randomized control trial of this targeted agent.